Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-28 · accession 0001104659-22-122556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-28 | 2022-11-28 | IOVA | Vogt Frederick G | GC, Interim CEO | P - Purchase | $5.98 | +1,000 | 2,000 | +100% | +$5,980 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-28 | P | A | 1,000 | $5.98 | 2,000 | D | — | — |